Apart from old age, the ε4 allele of the Apolipoprotein E (ApoE) gene stands out as the most relevant genetic risk factor for AD, offering an opening for assessing subclinical behavioral changes in very early disease stages and in mild cognitive impairment (MCI), which represents the symptomatic predementia phase [9]. The gene discussed is APOE; the disease is Alzheimer disease.